CNA Financial’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-5,310
| Closed | -$220K | – | 142 |
|
|
2022
Q3 | $220K | Buy |
5,310
+420
| +9% | +$17.4K | 0.08% | 161 |
|
|
2022
Q2 | $292K | Sell |
4,890
-640
| -12% | -$38.2K | 0.1% | 159 |
|
|
2022
Q1 | $402K | Sell |
5,530
-40
| -0.7% | -$2.91K | 0.12% | 159 |
|
|
2021
Q4 | $468K | Buy |
5,570
+390
| +8% | +$32.8K | 0.12% | 165 |
|
|
2021
Q3 | $467K | Sell |
5,180
-1,610
| -24% | -$145K | 0.13% | 167 |
|
|
2021
Q2 | $647K | Sell |
6,790
-170
| -2% | -$16.2K | 0.18% | 146 |
|
|
2021
Q1 | $792K | Sell |
6,960
-310
| -4% | -$35.3K | 0.24% | 127 |
|
|
2020
Q4 | $1.01M | Sell |
7,270
-870
| -11% | -$120K | 0.32% | 93 |
|
|
2020
Q3 | $669K | Buy |
8,140
+10
| +0.1% | +$822 | 0.25% | 108 |
|
|
2020
Q2 | $636K | Buy |
+8,130
| New | +$636K | 0.25% | 105 |
|